| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014191638 |
| P356 | DOI | 10.1186/1756-9966-30-71 |
| P8608 | Fatcat ID | release_g6biea7harglvlimrid62hhyaa |
| P953 | full work available at URL | https://europepmc.org/articles/PMC3173354 |
| https://europepmc.org/articles/PMC3173354?pdf=render | ||
| https://jeccr.biomedcentral.com/track/pdf/10.1186/1756-9966-30-71 | ||
| https://link.springer.com/content/pdf/10.1186/1756-9966-30-71.pdf | ||
| P932 | PMC publication ID | 3173354 |
| P698 | PubMed publication ID | 21798065 |
| P5875 | ResearchGate publication ID | 51529498 |
| P2093 | author name string | Hong Wang | |
| Jie Luo | |||
| Feng Gao | |||
| Xin Sun | |||
| Xiaoliang Zhao | |||
| Zhijun Sun | |||
| Biao Zhong | |||
| P2860 | cites work | The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro | Q30303631 |
| Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion | Q30304518 | ||
| Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility | Q30471919 | ||
| Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-α | Q34633205 | ||
| Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity | Q35749341 | ||
| Effects of Ulinastatin and Cyclophosphamide on the Growth of Xenograft Breast Cancer and Expression of CXC Chemokine Receptor 4 and Matrix Metalloproteinase-9 in Cancers | Q39659055 | ||
| Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C. | Q40064543 | ||
| AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in precl | Q40093939 | ||
| Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro | Q40605102 | ||
| Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways | Q40846518 | ||
| ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation | Q40864626 | ||
| Downstream targets of urokinase‐type plasminogen‐activator‐mediated signal transduction | Q41027822 | ||
| Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy | Q42256420 | ||
| Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling | Q42478267 | ||
| Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator | Q43786822 | ||
| The Urokinase-type Plasminogen Activator Receptor Mediates Tyrosine Phosphorylation of Focal Adhesion Proteins and Activation of Mitogen-activated Protein Kinase in Cultured Endothelial Cells | Q47859760 | ||
| Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator | Q52575847 | ||
| Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness | Q71171008 | ||
| Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis | Q72769139 | ||
| Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders | Q73965851 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | docetaxel | Q420436 |
| tumor invasion | Q60750433 | ||
| P304 | page(s) | 71 | |
| P577 | publication date | 2011-07-29 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK | |
| P478 | volume | 30 |
| Q53527300 | Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible? |
| Q39020785 | Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression |
| Q90681596 | The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth |
| Q38632598 | Ulinastatin - a newer potential therapeutic option for multiple organ dysfunction syndrome |
| Q48164348 | Ulinastatin decreases permeability of blood--brain barrier by inhibiting expression of MMP-9 and t-PA in postoperative aged rats |
| Q28545086 | Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy |
Search more.